Blog
RSS FeedPosted by Michael Wonder on 03 Oct 2019
What you need to know about pharmacare this election
3 October 2019 - We’ve had reports, election promises, advisory councils and investigations over the years, all examining the question ...
Posted by Michael Wonder on 03 Oct 2019
Dr. Brian O’Rourke to retire as CADTH’s President and CEO
3 October 2019 - Dr. Brian O’Rourke has announced his intention to retire from CADTH, effective 31 March 2020. ...
Posted by Michael Wonder on 24 Sep 2019
9 in 10 Canadians want national pharmacare: Heart & Stroke poll
24 September 2019 - Canadians overwhelmingly support a national pharmacare program, according to a new poll commissioned by Heart & ...
Posted by Michael Wonder on 24 Sep 2019
Canadian Health Policy Institute reports national pharmacare is unnecessary, bad for privately insured Canadians and costly for taxpayers: evidence counters Hoskins report
24 September 2019 - Constructive public discussion about a national pharmacare program in Canada is hindered by a lack of balance ...
Posted by Michael Wonder on 24 Sep 2019
Canada's Trudeau promises national prescription drug plan if re-elected
23 September 2019 - Canadian Prime Minister Justin Trudeau said on Monday that the Liberal Party would work with the ...
Posted by Michael Wonder on 24 Sep 2019
Institutional investors urging Congress to vote down CUSMA, citing effect on drug prices
23 September 2019 - A group of institutional investors representing more than US$500 billion is calling on the U.S. Congress ...
Posted by Michael Wonder on 19 Sep 2019
National pharmacare cheaper than healing people who can't afford their drugs
17 September 2019 - A national pharmacare program could potentially reduce prescription drug spending by aggregating the buying power of all ...
Posted by Michael Wonder on 18 Sep 2019
Health technology agency insights: informing modification of a qualitative benefit risk framework for health technology reassessment of prescription medications
16 September 2019 - This study's intent was to determine if a qualitative benefit risk framework could be used or modified ...
Posted by Michael Wonder on 16 Sep 2019
Canada decides: Leading parties plan to tackle ways to make medicine affordable
16 September 2019 - Canadian voters will be hearing a lot about a new national prescription drug program to fill a ...
Posted by Michael Wonder on 12 Sep 2019
Public plans covered only 26% of the 491 new drugs approved by Health Canada from 2009 to 2018; national pharmacare is an empty promise for 23.2 million Canadians now covered by private plans
11 September 2019 - Two new studies confirm the abysmal state of access to innovative medicines in Canada’s publicly funded drug ...
Posted by Michael Wonder on 12 Sep 2019
New rules will keep the best medications from desperate Canadians
12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...
Posted by Michael Wonder on 10 Sep 2019
Erosion of physician and patient treatment choice continues - Alliance for Safe Biologic Medicines raises concerns for patients as British Columbia expands biologics forced switching policy
10 September 2019 - On 5 September, the Government of British Columbia announced that it would be forcibly switching 1,700 patients ...
Posted by Michael Wonder on 10 Sep 2019
Canada releases final amendments to patented medicines pricing regulations
9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...
Posted by Michael Wonder on 08 Sep 2019
Trudeau’s drug price overhaul is set to cost drug makers billions
6 September 2019 - Canada revamps drug-pricing regime for first time since 1987. ...
Posted by Michael Wonder on 04 Sep 2019
NDP promises to restore special drugs program
4 September 2019 - Province paid deductible for chronic patients from 1968 to 2018. ...